SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals acquires Orit Laboratories LLC

01 Nov 2017 Evaluate

Alembic Pharmaceuticals through its 100% owned subsidiary, Alembic Pharmaceuticals Inc., has completed acquisition of West Caldwell, New Jersey, USA based generic drug developer Orit Laboratories LLC (Orit) along with real estate, owned by Okner Realty LLC (Okner).

The acquisition increases Alembic’s US product portfolio with 7 approved ANDAs, and 4 ANDAs pending approval. The acquisition also increases Alembic’s breadth and capabilities in the US with a competent R&D team bringing complementary skill sets in soft-gelatin based oral solids and oral liquids.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907.


Alembic Pharma Share Price

766.70 3.15 (0.41%)
22-Apr-2026 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.40
Dr. Reddys Lab 1215.55
Cipla 1228.55
Zydus Lifesciences 926.50
Lupin 2307.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×